RxDoctor Payments DataLook up a doctor →

Alan Hicks, NP

Family · Morganton, NCNPI 1720503972

Payments from drug & device makers

$12,445in general payments, 2019–2025

Across 681 payments — averaging $18.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$2K
  • AbbVie$1K
  • Lilly USA, LLC$1K
  • Stryker$1K
  • Novo Nordisk$1K
  • AstraZeneca$822
  • plus $5K from 53 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Teva Pharmaceuticals USA, Inc.107$1,880
AbbVie76$1,225
Lilly USA, LLC73$1,111
Stryker5$1,054
Novo Nordisk72$1,033
AstraZeneca42$822
Otsuka America Pharmaceutical, Inc.22$408
Bayer21$356
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC23$340
GSK18$334
Johnson & Johnson15$285
Lundbeck LLC12$272
Sanofi-aventis U.S. LLC11$237
Boehringer Ingelheim16$225
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)11$202
Astellas Pharma US Inc7$179
Pfizer10$175
Takeda Pharmaceuticals U.S.A., Inc.12$172
Corium, LLC14$170
Biohaven Pharmaceutical Holding Company Ltd.12$140
Novartis8$136
Biohaven Pharmaceuticals, Inc.6$116
Vanda Pharmaceuticals Inc.4$113
Abbott5$103
Merck6$97
Sumitomo Pharma America, Inc.4$93
Nestle Healthcare Nutrition Inc.5$78
Ardelyx, Inc.4$78
Phathom Pharmaceuticals, Inc.6$76
Mylan Specialty L.p.4$71
Ironshore Pharmaceuticals Inc.3$63
Viatris Specialty LLC3$55
Dexcom, Inc.4$54
Amgen4$52
Eisai Inc.3$49
Exact Sciences3$46
Daiichi Sankyo Inc.2$42
Mannkind Corporation3$39
Alkermes, Inc.2$37
Aimmune Therapeutics, Inc.1$33
Esperion Therapeutics, Inc.2$33
Insulet Corporation1$31
Kowa Pharmaceuticals America, Inc.2$30
Paratek Pharmaceuticals, Inc.1$27
Noven Therapeutics, LLC2$26
Forte Bio-pharma LLC1$25
Axsome Therapeutics, Inc.1$24
Scilex Pharmaceuticals Inc.1$22
Xeris Pharmaceuticals, Inc.1$21
Neurocrine Biosciences, Inc.1$20
Boston Scientific1$18
Tris Pharma Inc1$17
Almatica Pharma LLC1$16
Ironwood Pharmaceuticals, Inc1$15
Redhill Biopharma Inc.1$15
Medtronic1$14
Verona Pharma, Inc.1$14
Gilead1$13
Supernus Pharmaceuticals, Inc.1$13

How this compares

$12,445 in reported general payments places this provider in the 95th percentile of 4,522 family providers in North Carolina.

See all family providers in North Carolina →

Medicare billing

Part B allowed, 2024
$33,466
Medicare patients
108
Services billed
518

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Morganton

See the full list for North Carolina →

Where these figures come from

Is this you, or does something look wrong? →